| Zugriffe | |
|---|---|
| Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 197 |
| Oktober 2025 | November 2025 | Dezember 2025 | Januar 2026 | Februar 2026 | März 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU | 24 | 12 | 3 | 17 | 6 | 11 | 10 |
| Zugriffe | |
|---|---|
| 2019_Ertaş_etal.pdf | 334 |
| 2019_Ertaş_etal.pdf | 6 |
